Show
Sort by
-
Letter : safety of proton pump inhibitors during pregnancy-authors' reply
-
Systematic review with meta-analysis : the risks of proton pump inhibitors during pregnancy
-
Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy
-
Expert consensus : practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathies
-
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response
-
Editorial : infliximab trough levels and histological healing in ulcerative colitis-a step towards personalised biologic therapy
-
- Journal Article
- A1
- open access
Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes
-
Systematic review with meta-analysis : prevalence, risk factors and costs of aminosalicylate use in Crohn's disease
-
Review article: dose optimisation of infliximab for acute severe ulcerative colitis
-
Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease